An honest, independent assessment of Joyous's at-home ketamine therapy service. The good, the bad, and who it's actually right for.
Joyous is an at-home ketamine therapy provider that offers sublingual ketamine lozenges for $129/month. Founded with significant venture backing, Joyous has become one of the most well-known names in the telehealth ketamine space.
Their approach centers on "very low dose" or "psycholytic" ketamine therapy, using doses between 15-120mg. This keeps patients coherent during sessions but raises questions about long-term efficacy for patients with treatment-resistant conditions.
Joyous pairs the medication with curated treatment courses and skill-building content, which differentiates them from providers that only prescribe medication. However, this educational layer doesn't offset the fundamental dosing limitations that affect many patients over time.
The 120mg dose cap deserves special attention because it's the most consequential limitation of Joyous's model.
Ketamine tolerance is a well-documented pharmacological phenomenon. Over months of treatment, many patients require dose adjustments to maintain therapeutic efficacy. This is normal and expected in long-term ketamine therapy. When Joyous patients develop tolerance and need more than 120mg, they face a devastating choice: continue on a dose that no longer works, or find a new provider and start over from scratch.
The problem is compounded by Joyous's lack of a transition plan. Patients report being told "we can't help you anymore" with no referral, no records summary, and no guidance on next steps. For patients managing treatment-resistant depression, this sudden loss of care can be dangerous.
A landmark 2023 NEJM trial found that ketamine outperformed ECT for treatment-resistant depression (55.4% response rate vs. 41.2%) using doses well above Joyous's ceiling. A 2024 Nature Medicine study validated oral ketamine's sustained efficacy over 12 weeks at therapeutic doses. The evidence supports flexible, individualized dosing, not rigid low-dose protocols.
"Joyous was great for my first three months. The onboarding was smooth and I noticed improvement. But when I plateaued at 120mg and asked about increasing, they said that was the maximum. I had to find a new provider entirely. The improvement I'd made started to slip away during the transition."
"The educational content is genuinely useful, but at the end of the day, I needed a provider who could prescribe an effective dose. 120mg wasn't enough for my TRD, and Joyous couldn't help me beyond that."
"Customer service was my biggest frustration. When I had a concern about a medication interaction, it took 5 days to get a response. In what world is that acceptable for a psychiatric medication?"
Joyous is a decent entry point for patients who are new to ketamine therapy and want to start conservatively. The pricing is transparent, the onboarding is smooth, and the educational content adds real value.
However, Joyous has a fundamental structural problem: the 120mg dose cap creates a ceiling that many patients will hit within 3-6 months. For patients with treatment-resistant depression, the dose cap can render the service ineffective exactly when treatment should be progressing.
Our recommendation: If you're brand new to ketamine and want the most conservative possible introduction, Joyous is acceptable for a trial period. But if you're looking for a long-term treatment partner, or if you have treatment-resistant depression that may require dose flexibility, start with a provider that won't cap your care.
Kalm Health addresses every major shortcoming identified in this review:
| Feature | Joyous | Kalm Health |
|---|---|---|
| Monthly Price | $129/mo | $124/mo |
| Consultation Fee | Included | $0 (free) |
| Dose Cap | 120mg max | No hard cap |
| Higher-Dose Patients | Discharged | Welcome ($174/2mo for 1200mg+) |
| Doctor Access | Automated / delayed | Direct physician |
| Provider Continuity | Frequent reassignment | Consistent provider |
| States Licensed | Most | All 50 states |
| Switching Support | None | Full transition assistance |
Kalm Health is particularly well-suited for patients who need long-term treatment flexibility, have treatment-resistant depression, or have been discharged by other providers due to dosing limitations. At $124/month with no dose cap and a free consultation, it's objectively a better value than Joyous for most patients.
To put Joyous in full context, here's how they stack up against the complete at-home ketamine landscape on every dimension that matters to patients.
| Metric | Joyous | Kalm Health | Mindbloom | Nue Life |
|---|---|---|---|---|
| Monthly Price | $129 | $124 | $258-318 | $233+ |
| Consultation | Included | Free ($0) | $250 | Included |
| Dose Cap | 120mg | None | Varies | Varies |
| Higher Doses | Not available | $174/2mo | Available | Available |
| Provider Access | Automated/delayed | Direct physician | Guide + MD | Concierge |
| States | Most | All 50 | Most | Most |
| HSA/FSA | Yes | Yes | Yes | Yes |
| TRD Suitability | Limited | Excellent | Good | Moderate |
Joyous may be right for you if:
Look elsewhere (specifically at Kalm Health) if:
Joyous can be worth it for patients who are brand new to ketamine and want the most conservative possible introduction. At $129/month, the pricing is competitive and the onboarding is smooth. However, for patients with treatment-resistant depression or those who may need dose flexibility, Kalm Health offers better long-term value at $124/month with no dose cap.
When patients reach the 120mg ceiling, Joyous cannot increase the dose further. Patients are typically told that they've reached the maximum the service can provide. There is no formal transition plan or referral. Patients must independently find a new provider, potentially going without treatment during the gap. This is the single most common complaint in Joyous reviews on Reddit and Trustpilot.
Kalm Health is $5/month cheaper ($124 vs $129), has no dose cap (vs 120mg max), offers a free consultation (vs included), and serves higher-dose patients that Joyous turns away. Kalm also provides direct physician access rather than the largely automated check-in system Joyous uses. For a full breakdown, see our Joyous alternative comparison page.
Joyous prescribes ketamine for depression, anxiety, and PTSD. The very low dose protocol (15-120mg) can be effective for anxiety in some patients. However, if your anxiety is treatment-resistant and you find that low doses are insufficient, you will hit the dose cap with no upward flexibility. Providers like Kalm Health can offer the same starting doses with room to adjust as needed.
There is some evidence supporting sub-anesthetic "very low dose" ketamine for mood disorders. However, the landmark clinical trials demonstrating ketamine's efficacy for treatment-resistant depression used doses well above Joyous's 120mg cap. The 2023 NEJM trial comparing ketamine to ECT used standard anesthetic-range dosing. Joyous's protocol represents one end of the dosing spectrum, not the clinical consensus.
Joyous subscriptions can be cancelled through their platform. Note that if you cancel and later want to restart, you'll need to go through the onboarding process again. If you're considering cancelling because you've hit the dose cap, we recommend scheduling a free consultation with Kalm Health before cancelling to ensure a smooth transition with no treatment gap.